GlassScriptPhysician profile
James Barrett Kyle
NPI 1285876359
$110,752.45
in general payments reported to CMS, 2019-2025
18 companies · $72K in 2025
The $72K reported for 2025 was more than what 96% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,419 · 2020: $1,324 · 2021: $1,866 · 2022: $5,967 · 2023: $8,544 · 2024: $19K · 2025: $72K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $76K · Travel and Lodging: $13K · Consulting Fee: $7,139 · Food and Beverage: $3,061.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $76,465.00 |
| Travel and Lodging | $12,512.65 |
| Consulting Fee | $7,138.53 |
| Food and Beverage | $3,060.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $107,841.29 | 2019-2025 | Avenir, G7, Rosa |
| Stryker Corporation | $980.03 | 2019-2025 | Mako, Zipseal 24 Surgical Skin Closure Kit, Triathlon |
| Medtronic, INC. | $540.36 | 2023 | Aquamantys(Tm) |
| Smith+Nephew, INC. | $478.25 | 2019-2022 | |
| Hikma Pharmaceuticals USA | $305.33 | 2024 | Combogesic IV |
| Abiomed | $213.72 | 2024 | Impella |
| Pacira Pharmaceuticals Incorporated | $81.28 | 2023-2025 | Iovera, Zilretta, Exparel |
| Baxter Healthcare | $74.30 | 2022 | |
| Medacta USA, INC. | $55.02 | 2024-2025 | Gmk Sphere |
| Ethicon US, LLC | $43.86 | 2025 | Vistaseal, Stratafix |
| Bioventus LLC | $28.31 | 2025 | Xcell |
| Avanos Medical | $22.84 | 2024 | On-Q* Pump and Accessories |
| Boston Scientific Corporation | $16.33 | 2025 | General - Pain Management |
| Heraeus Medical, LLC. | $15.42 | 2019 | |
| Mirum Pharmaceuticals, INC. | $15.37 | 2025 | Livmarli |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthogenrx INC. | $15.08 | 2019 | |
| Horizon Therapeutics Plc | $12.87 | 2019 | |
| Kci USA, INC. | $12.79 | 2023 | Prevena, V.A.C. Dermatac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Kyle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.